WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000024911) HUMAN PHOSPHOLIPASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/024911    International Application No.:    PCT/US1999/025021
Publication Date: 04.05.2000 International Filing Date: 27.10.1999
Chapter 2 Demand Filed:    17.05.2000    
IPC:
A61K 38/00 (2006.01), C12N 9/20 (2006.01)
Applicants: INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304 (US) (For All Designated States Except US).
HILLMAN, Jennifer, L. [US/US]; (US) (For US Only).
BANDMAN, Olga [US/US]; (US) (For US Only).
GUEGLER, Karl, J. [CH/US]; (US) (For US Only).
CORLEY, Neil, C. [US/US]; (US) (For US Only).
BAUGHN, Mariah, R. [US/US]; (US) (For US Only).
AZIMZAI, Yalda [US/US]; (US) (For US Only).
LAL, Preeti [IN/US]; (US) (For US Only).
LU, Dyung, Aina, M. [US/US]; (US) (For US Only)
Inventors: HILLMAN, Jennifer, L.; (US).
BANDMAN, Olga; (US).
GUEGLER, Karl, J.; (US).
CORLEY, Neil, C.; (US).
BAUGHN, Mariah, R.; (US).
AZIMZAI, Yalda; (US).
LAL, Preeti; (US).
LU, Dyung, Aina, M.; (US)
Agent: BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304 (US).
HAMLET-COX, Diana; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304 (US)
Priority Data:
09/181,317 27.10.1998 US
  27.10.1998 US
09/234,726 21.01.1999 US
  21.01.1999 US
Title (EN) HUMAN PHOSPHOLIPASES
(FR) PHOSPHOLIPASES HUMAINES
Abstract: front page image
(EN)The invention provides human phospholipases (HPPL) and polynucleotides which identify and encode HPPL. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HPPL.
(FR)L'invention concerne des phospholipases humaines (HPPL) et des polynucléotides qui identifient et codent les HPPL. L'invention concerne aussi des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin des procédés pour diagnostiquer, traiter ou prévenir les troubles liés à l'expression de HPPL.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)